$AEON
AEON Biopharma, Inc.
XASE•Health Care•Pharmaceutical Preparations
$0.265
▼-5.02%-$0.014
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is AEON down today? It is at $0.265 (-5.02%), and our scanner flagged it 155 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AEON spikes, and full due diligence on AEON — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AEON 155 times in the last 30 days. Create a free account to track $AEON, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AEON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AEON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPriced share offering, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 529.3% of the tradeable float is in play - 529.3% more can still be issued.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
195,591,436 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $50.0M in size · Priced at $0.3221/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lynch Timothy P Beneficial Owner (10%) | Bought (open market) | +1.15M 2.3% of company | added 21% | 6.50M | $242K at $0.210 | Aug 19, 26 |
Carter Eric G Director | Acquired (grant/award) | +223K 0.4% of company | added 100% | 259K | n/a | Jun 17, 26 |
Fischer Jost Director | Acquired (grant/award) | +223K 0.4% of company | added 83% | 489K | n/a | Jun 17, 26 |
Forth Marc Director | Acquired (grant/award) | +223K 0.4% of company | added 30% | 973K | n/a | Jun 17, 26 |
Palmisano Robert J Director | Acquired (grant/award) | +223K 0.4% of company | added 100% | 259K | n/a | Jun 17, 26 |
Thunen Shelley B Director | Acquired (grant/award) | +223K 0.4% of company | added 100% | 259K | n/a | Jun 17, 26 |
Bencich John Officer | Acquired (grant/award) | +755K 1.5% of company | n/a | 755K | n/a | Apr 2, 26 |
Sy Jennifer Officer | Acquired (grant/award) | +926K 1.9% of company | added 100% | 1.50M | n/a | Mar 4, 26 |
Wilson Alexander Blair Officer | Acquired (grant/award) | +1.32M 2.6% of company | added 100% | 2.18M | n/a | Mar 4, 26 |
Oh Chad Officer | Acquired (grant/award) | +1.32M 2.6% of company | added 100% | 2.18M | n/a | Mar 4, 26 |
Bancroft Robert E. Officer | Acquired (grant/award) | +3.00M 6.0% of company | added 100% | 3.18M | n/a | Feb 17, 26 |
Sy Jennifer Officer | Acquired (grant/award) | +575K 1.2% of company | added 100% | 575K | n/a | Feb 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AEON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AEON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AEON last traded at $0.265, down 5.02% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The AEON Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AEON 155 times in the last 30 days.
AEON (AEON Biopharma, Inc.) trades on XASE, with a market cap of about $14M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AEON for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AEON discussion
Sign in to ask a question or join the discussion.